BELLEROPHON THERAPEUTICS, INC. SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 27th, 2017 • Bellerophon Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 27th, 2017 Company Industry JurisdictionThis Securities Purchase Agreement (“Agreement”) is made as of September 26, 2017 (the “Effective Date”), by and among Bellerophon Therapeutics, Inc., a Delaware corporation (the “Company”), and each of those persons and entities, severally and not jointly, listed as a Purchaser on the Schedule of Purchasers attached as Exhibit A hereto (the “Schedule of Purchasers”). Such persons and entities are hereinafter collectively referred to herein as “Purchasers” and each individually as a “Purchaser.”
REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 27th, 2017 • Bellerophon Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 27th, 2017 Company Industry JurisdictionThis Registration Rights Agreement (this “Agreement”) is made and entered into as of September 26, 2017, by and among Bellerophon Therapeutics, Inc., a Delaware corporation (the “Company”), and the investors signatory hereto (each a “Purchaser” and collectively, the “Purchasers”).
WARRANT TO PURCHASE SHARES OF COMMON STOCK OFWarrant Agreement • September 27th, 2017 • Bellerophon Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 27th, 2017 Company Industry JurisdictionThis Warrant is issued to [ ], or its registered assigns (including any successors or assigns, the “Purchaser”), pursuant to that certain Securities Purchase Agreement, dated as of September 26, 2017, among Bellerophon Therapeutics, Inc., a Delaware corporation (the “Company”), the Purchaser and certain other purchasers thereunder (the “Purchase Agreement”) and is subject to the terms and conditions of the Purchase Agreement.